To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Intramuscular vs. Intra-articular Glucocorticoid Injection for Knee Osteoarthritis

Download
Share
Reprints
Cite This
About
+ Favorites
Download
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
June 2022

Intramuscular vs. Intra-articular Glucocorticoid Injection for Knee Osteoarthritis

Vol: 236| Issue: 1| Number:1| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Effect of Intramuscular vs Intra-articular Glucocorticoid Injection on Pain Among Adults With Knee Osteoarthritis: The KIS Randomized Clinical Trial.

JAMA Netw Open . 2022 Apr 1;5(4):e224852.

Contributing Authors:
Q Wang MF Mol PK Bos DMJ Dorleijn M Vis J Gussekloo PJE Bindels J Runhaar SMA Bierma-Zeinstra

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

One hundred and forty-five patients with knee osteoarthritis were randomized in this non-inferiority trial to receive an intramuscular glucocorticoid injection (n=74) or an intra-articular glucocorticoid injection (n=71). The primary outcome of interest was pain at 4 weeks as measured with the Knee Injury and Osteoarthritis Outcome Score (KOOS) pain sub-scale. Secondary outcomes included KOOS pain...

Join the Conversation

Please Login or Join to leave comments.